Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

9,012 public trials 1,844 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

NCT00078858

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, +220 more
Locations
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • Rocky Mountain Cancer Centers-Midtown Denver, Colorado, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
View Trial Details
Completed

Allo-hNHL (FluBuCy)

NCT00785330

Conditions
Disease Attributes, Graft vs Host Disease, Hemic and Lymphatic Diseases, +16 more
Locations
  • Universitätsklinikum Heidelberg Heidelberg, Baden-Würtenberg, Germany
  • Universitätsklinikum Marburg Marburg, Hesse, Germany
  • Universitätsklinikum und Poliklinik Homburg, Saarland, Germany
  • University Hospital Goettingen Göttingen, Germany
View Trial Details
Completed

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma

NCT02567656

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • City of Hope Duarte, California, United States
  • Chao Family Comprehensive Cancer Center University of California Irvine Orange, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
View Trial Details
Completed

Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry

NCT01110733

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • DCH Cancer Treatment Center Tuscaloosa, Alabama, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 68 locations
View Trial Details
Completed

A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)

NCT01059630

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Southern Cancer Center, PC Mobile, Alabama, United States
  • Dr. Donald W. Hill, MD, FACP Casa Grande, Arizona, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Kaiser Permanente - Bellflower Bellflower, California, United States
View all 121 locations
View Trial Details
Completed

A Study of SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma

NCT00343564

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +9 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Cornell University Medical Center New York, United States
  • Memorial Sloan-Kettering Caner Center New York, United States
  • Herbert Irving Comprehensive Cancer Center New York, United States
View Trial Details
Completed

Clinical Trial to Determinate Dose, Security and Efficacy or Lenalidomide and Rituximab (LR)-ESHAP in Patients With Diffuse Large B-cell Lymphoma

NCT02340936

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • ICO- Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain
  • ICO- Hospital Duran i Reynals L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital del Mar Barcelona, Spain
  • Hospital Clinic i Provincial de Barcelona Barcelona, Spain
View Trial Details

Related conditions